CCST9006 Chap.3 Genes, Genome and DNA Testing
Genes, Genome and DNA Testing
Detection is not interpretation
This chapter follows a gene through transcription, translation, protein assembly and phenotype, then adds the laboratory controls needed to trust a PCR signal.
A positive control tests whether detection is possible, a negative control exposes contamination or non-specific amplification, and a sample-level amplification control distinguishes absence from reaction failure.
Uncertainty continues after the assay
A variant of uncertain significance requires clinical, family, population and functional evidence before classification can change.
Consumer testing also raises questions about secondary use, access, security, relatives and discrimination. Genome editing adds another boundary: therapeutic aim, inherited change and enhancement are different decisions and require different justification.
What this chapter covers
- 01
Gene, transcript, protein and phenotype
- 02
Alleles and protein assembly
- 03
PCR positive and negative controls
- 04
Variants of uncertain significance
- 05
DNA information, privacy and relatives
- 06
Therapy, inherited editing and enhancement
Worked example · free
Interpret an apparently blank assay
- 3Read the sample control first.
- 2Separate batch performance from sample performance.
- 3State the valid next action.
Key terms
- Allele
- One version of a gene carried at a particular genetic location.
- Transcription
- Production of an RNA copy from a DNA template.
- Translation
- Use of an RNA sequence to assemble a protein.
- Positive Control
- A control expected to produce a signal and confirm detection capability.
- Uncertain Variant
- A variant lacking enough evidence for harmless or disease-causing classification.
Genes, Genome and DNA Testing FAQ
Why can a technically correct DNA result remain clinically uncertain?
The assay may detect a sequence difference accurately while evidence about its biological effect, penetrance or benefit of acting remains incomplete. Detection, classification, prediction and decision are separate stages. Clinical features, family segregation, population observations and functional studies may be needed before the result can guide care.
What do positive and negative PCR controls prove?
A positive control shows that the reaction can produce the expected signal when the target is present. A negative control tests whether a signal appears without the target. A separate sample amplification control can reveal reaction failure. Together they distinguish absence, contamination and technical failure.
Why does a DNA result affect relatives?
Genetic information is shared across biological relationships, so one person's result can imply risks or traits for family members who did not request testing. Consent and privacy policies therefore need to consider secondary use, access, communication, withdrawal and relational consequences rather than treating the sequence as isolated data.
What should happen when the sample control fails?
Withhold the genotype call and repeat from an appropriate sample after investigating extraction, sample quality and reaction setup. Working batch controls show that reagents can function, but they do not prove that this particular sample amplified. A blank sample control turns apparent absence into an uninterpretable result.
How can functional evidence help classify a variant?
A functional study can test whether the variant changes a biologically relevant process, but its value depends on whether the model reproduces the disease mechanism. Combine it with clinical, family and population evidence. One artificial assay should not be treated as a complete prediction of disease in a person.
What is the danger of jumping from genotype to phenotype?
The jump hides transcription, protein assembly, biochemical function, penetrance, environment and other biological influences. Write the intermediate links and state which have evidence. This reveals whether the result supports a mechanism, a probability or only the presence of a sequence difference.
How should uncertain results be communicated?
State what was detected, why the classification remains uncertain and what evidence could change it. Avoid translating uncertainty into either reassurance or diagnosis. Explain whether any action is supported now, what follow-up is appropriate and which decisions should wait for stronger evidence.
Assessment move
For every result, write four headings: assay, variant, person and action. Under assay, check controls. Under variant, state the justified classification. Under person, add phenotype and family evidence. Under action, compare benefit and harm. Never let a later stage silently borrow certainty from an earlier one.
Rehearse three failure cases: a positive sample with a contaminated negative control, a blank sample with a failed amplification control, and a clean variant call with uncertain significance. Explain why each stops at a different stage. Then add one privacy question and one question about relatives. This keeps the technical interpretation connected to the decisions and people affected by the result.
Working through Genes, Genome and DNA Testing in CCST9006? Sia is AskSia’s AI Health and Medicine tutor — ask any CCST9006 Genes, Genome and DNA Testing question and get a clear, step-by-step explanation grounded in how CCST9006 is taught and assessed. Read this chapter free, then take your hardest questions to Sia.